Imbalance in seminal fluid MIF indicates male infertility

Molecular Medicine

Volumn 13, Issue 3-4, 2007, Pages 199-202

  Aljabari, Bayan ^a   Calogero, Aldo E ^b   Perdichizzi, Anna ^b   Vicari, Enzo ^b   Karaki, Raja ^c   Lahloub, Tarek ^c   Zatari, Rashed ^d   El Abed, Khaleel ^d   Nicoletti, Ferdinando ^b   Miller, Edmund J ^a   Pavlov, Valentin A ^a   Al Abed, Yousef ^a,e  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b UNIVERSITY OF CATANIA   (Italy)

^c Al Amal Maternity Hospital   (Jordan)

^d Sperm Act Inc   (Palestine)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MACROPHAGE MIGRATION INHIBITION FACTOR;

APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; MALE; MALE INFERTILITY; PRIORITY JOURNAL; PROTEIN DETERMINATION; SEMEN ANALYSIS; SEMINAL PLASMA; SPERMATOZOON MOTILITY;

ANNEXIN A5; APOPTOSIS; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INDICATORS AND REAGENTS; INFERTILITY, MALE; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; PROPIDIUM; SEMEN; SPERM MOTILITY; SPERMATOZOA;

EID: 34250665793     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/2006-00114.Aljabari     Document Type: Article

References (15)

1. Calandra T, Roger T. (2003) Macrophage migration inhibitory factor: a regulator of innate immunity. Nat. Rev. Immunol. 3:791-800.
2. Riedemann NC, Guo RF, Ward PA. (2003) Novel strategies for the treatment of sepsis. Nat. Med. 9:517-24.
3. Cvetkovic I et al. (2005) Critical role of macrophage migration inhibitory factor activity in experimental autoimmune diabetes. Endocrinology 146:2942-51.
4. Al-Abed Y et al. (2005) ISO-1 binding to the tautomerase active site of MIF inhibits its pro-inflammatory activity and increases survival in severe sepsis. J. Biol. Chem. 280:36541-4.
5. Rosengren E et al. (1996) The immunoregulatory mediator macrophage migration inhibitory factor (MIF) catalyzes a tautomerization reaction. Mol. Med. 2:143-9.
6. Lubetsky JB et al. (2002) The tautomerase active site of macrophage migration inhibitory factor is a potential target for discovery of novel anti-inflammatory agents. J. Biol. Chem. 277:24976-82.
7. Dios A et al. (2002) Inhibition of MIF bioactivity by rational design of pharmacological inhibitors of MIF tautomerase activity. J. Med. Chem. 45:2410-6.
8. Senter PD et al. (2002) Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites. Proc. Natl. Acad. Sci. U. S. A. 99:144-9.
9. Arcuri F, Cintorino M, Vatti R, Carducci A, Liberatori S, Paulesu L. (1999) Expression of macrophage migration inhibitory factor transcript and protein by 1st-trimester human trophoblasts. Biol. Reprod. 60:1299-303.
10. Arcuri F et al. (2001) Macrophage migration inhibitory factor in the human endometrium: expression and localization during the menstrual cycle and early pregnancy. Biol. Reprod. 64:1200-5.
11. Eickhoff R et al. (2004) Influence of macrophage migration inhibitory factor (MIF) on the zinc content and redox state of protein-bound sulphydryl groups in rat sperm: indications for a new role of MIF in sperm maturation. Mol. Hum. Reprod. 10:605-11.
12. Frenette G, Legare C, Saez F, Sullivan R. (2005) Macrophage migration inhibitory factor in the human epididymis and semen. Mol. Hum. Reprod. 11:575-82.
13. Utleg AG et al. (2003) Proteomic analysis of human prostasomes. Prostate 56:150-61.
14. Meinhardt A et al. (1996) Macrophage migration inhibitory factor production by Leydig cells: evidence for a role in the regulation of testicular function. Endocrinology 137:5090-5.
15. Frenette G, Tremblay RR, Dube JY, Lazure C, Lemay M. (1998) High concentrations of the macrophage migration inhibitory factor in human seminal plasma and prostatic tissues. Arch. Androl. 41:185-93.